Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review
Felix Clay, David Howett, James FitzGerald, Paul Fletcher, Dennis Chan, Annabel Price
Publication from 2020, in Journal of Alzheimer's Disease, 75(1): 23–43, on quality of life and dementia and Alzheimer's. Part of the library of studies on virtual reality in healthcare collected by RVer.
Details
- Title
- Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review
- Authors
- Felix Clay, David Howett, James FitzGerald, Paul Fletcher, Dennis Chan, Annabel Price
- Year
- 2020
- Published in
- Journal of Alzheimer's Disease, 75(1): 23–43
- Type
- Independent publication
- Language
- English
This page describes a published reference by independent authors. It is not a claim about RVer's performance and does not replace clinical assessment. The Class I medical device registration (EUDAMED, Basic UDI-DI 56006195127RVERTZ, and INFARMED, Portugal, CDM 94571546) covers the RVer base product.
Other references on the same topic
- Therapeutic Virtual Reality (RVer) Findings in Older Adults’ Cognitive Impairment and DepressionRita Ferreira · 2022
- Therapeutic Virtual Reality: Theory, Applications, and Impact on the People’s Health and Well-beingJoão Fernandes Thomaz · 2026
- A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and DementiaValeria Manera · 2016
- A Mini-Review of Virtual Reality-Based Interventions to Promote Well-Being for People Living with Dementia and Mild Cognitive ImpairmentNathan M. D’Cunha · 2019
- A nature-immersive virtual reality intervention to support hospice family caregivers: Qualitative findings from a pilot studyPatano · 2024
- An Intervention on Anxiety Symptoms in Moderate Alzheimer's Disease through Virtual Reality: A Feasibility Study and Lessons LearnedDesirée Sánchez-Nieto · 2023